MedTech Dive April 11, 2022
Elise Reuter

As more software-based treatments gain FDA clearance, they still face hurdles ahead in getting insurance reimbursement and garnering adoption among patients and physicians.

In 2020, the Food and Drug Administration cleared Akili Interactive’s video game to improve attention in kids with ADHD. It was the first time that a video game for treatment was cleared by the agency, and is one example of a digital therapeutic, a class of software-based treatments with FDA indications.

Now, as the market is further developing, these companies have built up big ambitions.

Corey McCann, the CEO of Pear Therapeutics, which has three FDA-cleared digital treatments, hopes to make them the standard of care and garner widespread insurance coverage. After going public last year,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Apps, Digital Health, FDA, Govt Agencies, Technology
Screenagers to Silver Surfers: How each generation clicks with care
Digital Health Rewired 2025: 10 Key Talking Points
New Law Extends Telehealth Flexibilities Another 6 Months
Better Science, Better Medicine: How Clinical Research Advances Women’s Health
Digital Health Adoption Trends by Each Generation: From Gen Z to Boomers

Share This Article